NYSE:AVNS - Avanos Medical Stock Price, Forecast & News

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Avanos Medical Inc (NYSE:AVNS) released its quarterly earnings data on Tuesday, November, 5th. The company reported $0.30 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.32 by $0.02. The business had revenue of $171.40 million for the quarter, compared to analysts' expectations of $179.98 million. Avanos Medical had a negative net margin of 6.20% and a positive return on equity of 3.92%. Avanos Medical's revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period last year, the company earned $0.37 earnings per share. View Avanos Medical's Earnings History.

Avanos Medical is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Avanos Medical.

Avanos Medical will be holding an earnings conference call on Tuesday, February 25th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

6 brokers have issued 1 year target prices for Avanos Medical's stock. Their forecasts range from $30.00 to $65.00. On average, they anticipate Avanos Medical's stock price to reach $42.00 in the next twelve months. This suggests a possible upside of 41.7% from the stock's current price. View Analyst Price Targets for Avanos Medical.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 2 sell ratings, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Avanos Medical.

Media stories about AVNS stock have been trending somewhat positive recently, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Avanos Medical earned a media sentiment score of 1.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Avanos Medical.

Some companies that are related to Avanos Medical include MSA Safety (MSA), Wound Management Technologies (WNDM), Wright Medical Group (WMGI), Inogen (INGN), Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), Sientra (SIEN), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), COLLPLANT HOLDI/S (CLGN), Bionik Laboratories (BNKL), NanoVibronix (NAOV) and Allied Healthcare Products (AHPI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly Clark (KMB), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Honeywell International (HON), Procter & Gamble (PG), AT&T (T), Verizon Communications (VZ), Cisco Systems (CSCO) and Thermo Fisher Scientific (TMO).

Avanos Medical's stock is owned by many different of institutional and retail investors. Top institutional investors include Champlain Investment Partners LLC (6.96%), Paradice Investment Management LLC (4.64%), State Street Corp (3.78%), Victory Capital Management Inc. (3.45%), Victory Capital Management Inc. (3.42%) and Goldman Sachs Group Inc. (3.11%). Company insiders that own Avanos Medical stock include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Institutional Ownership Trends for Avanos Medical.

AVNS stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., FMR LLC, Heartland Advisors Inc., Paradice Investment Management LLC, Jacobs Levy Equity Management Inc., California Public Employees Retirement System and Bank of New York Mellon Corp. View Insider Buying and Selling for Avanos Medical.

AVNS stock was bought by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Schonfeld Strategic Advisors LLC, Cove Street Capital LLC, Confluence Investment Management LLC, Eagle Asset Management Inc., Madison Asset Management LLC, Barclays PLC and State Street Corp. Company insiders that have bought Avanos Medical stock in the last two years include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Insider Buying and Selling for Avanos Medical.

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AVNS stock can currently be purchased for approximately $29.65.

Avanos Medical has a market capitalization of $1.42 billion and generates $652.30 million in revenue each year. The company earns $57.50 million in net income (profit) each year or $0.82 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.View Additional Information About Avanos Medical.

The official website for Avanos Medical is http://www.halyardhealth.com/.

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]